Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Raji E. Joseph"'
Publikováno v:
Journal of Structural Biology: X, Vol 6, Iss , Pp 100061- (2022)
Cell surface receptors such as the T-cell receptor (TCR) and B-cell receptor (BCR) engage with external stimuli to transmit information into the cell and initiate a cascade of signaling events that lead to gene expression that drives the immune respo
Externí odkaz:
https://doaj.org/article/8e4f51776dd241dea5c38b325a6e6f40
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Since Dr. Ogden Bruton’s 1952 paper describing the first human primary immunodeficiency disease, the peripheral membrane binding signaling protein, aptly named Bruton’s tyrosine kinase (BTK), has been the target of intense study. Dr. Bruton’s d
Externí odkaz:
https://doaj.org/article/dac1612540c9495b93691264c444ed2f
Publikováno v:
eLife, Vol 9 (2020)
Bruton’s tyrosine kinase (BTK) is targeted in the treatment of B-cell disorders including leukemias and lymphomas. Currently approved BTK inhibitors, including Ibrutinib, a first-in-class covalent inhibitor of BTK, bind directly to the kinase activ
Externí odkaz:
https://doaj.org/article/a1e7c59bd7424b1ea7e5693fd82af544
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology
Since Dr. Ogden Bruton’s 1952 paper describing the first human primary immunodeficiency disease, the peripheral membrane binding signaling protein, aptly named Bruton’s tyrosine kinase (BTK), has been the target of intense study. Dr. Bruton’s d
Autor:
John R. Engen, Wayland Yeung, Amy H. Andreotti, Natarajan Kannan, Raji E. Joseph, Thomas E. Wales, Annie Kwon, Neha Amatya, D. Bruce Fulton
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance Bruton’s tyrosine kinase (BTK) is targeted in treatment of immune cancers. As patients experience drug resistance, there is a need for alternative approaches to inhibit BTK. Other recently published findings clarify the role of the BTK
Autor:
Raji E. Joseph, Jacques Lowe, D. Bruce Fulton, John R. Engen, Thomas E. Wales, Amy H. Andreotti
Publikováno v:
J Mol Biol
Mutations in PLCγ, a substrate of the tyrosine kinase BTK, are often found in patients who develop resistance to the BTK inhibitor Ibrutinib. However, the mechanisms by which these PLCγ mutations cause Ibrutinib resistance are unclear. Under normal
Autor:
D. Bruce Fulton, Amy H. Andreotti, Thomas E. Wales, Neha Amatya, John R. Engen, Raji E. Joseph
Publikováno v:
eLife, Vol 9 (2020)
eLife
eLife
Bruton’s tyrosine kinase (BTK) is targeted in the treatment of B-cell disorders including leukemias and lymphomas. Currently approved BTK inhibitors, including Ibrutinib, a first-in-class covalent inhibitor of BTK, bind directly to the kinase activ
Publikováno v:
Annual Review of Immunology. 36:549-578
Signaling through the T cell antigen receptor (TCR) activates a series of tyrosine kinases. Directly associated with the TCR, the SRC family kinase LCK and the SYK family kinase ZAP-70 are essential for all downstream responses to TCR stimulation. In
Publikováno v:
Biochemistry. 56:2938-2949
Pleckstrin homology (PH) domains are well-known as phospholipid binding modules, yet evidence that PH domain function extends beyond lipid recognition is mounting. In this work, we characterize a protein binding function for the PH domain of interleu